Rep. Lisa C. McClain Purchases Shares of Ingredion Incorporated (NYSE:INGR)

Key Points

• Representative Lisa C. McClain purchased shares of Ingredion Incorporated (NYSE:INGR) valued between $1,001 and $15,000 on September 25th, as disclosed in a filing on October 22nd.
• Ingredion recently reported a decrease in quarterly revenue of 2.4% year-over-year, with earnings per share of $2.87, surpassing analyst expectations of $2.78.
• The company increased its quarterly dividend to $0.82 per share, up from $0.80, resulting in an annualized yield of 2.8% for shareholders.

Representative Lisa C. McClain (R-Michigan) recently bought shares of Ingredion Incorporated NYSE: INGR. In a filing disclosed on October 22nd, the Representative disclosed that they had bought between $1,001 and $15,000 in Ingredion stock on September 25th. The trade occurred in the Representative's "CHARLES SCHWAB BROKERAGE ACCOUNT 924" account.

Representative Lisa C. McClain also recently made the following trade(s):

• Purchased $1,001 - $15,000 in shares of FMC NYSE: FMC on 9/25/2025.
• Sold $1,001 - $15,000 in shares of Merit Medical Systems NASDAQ: MMSI on 9/25/2025.
• Purchased $1,001 - $15,000 in shares of Darden Restaurants NYSE: DRI on 9/25/2025.
• Purchased $1,001 - $15,000 in shares of ASML NASDAQ: ASML on 9/25/2025.
• Purchased $1,001 - $15,000 in shares of Kenvue NYSE: KVUE on 9/25/2025.
• Sold $1,001 - $15,000 in shares of Beacon Financial NYSE: BBT on 9/25/2025.
• Sold $1,001 - $15,000 in shares of British American Tobacco NYSE: BTI on 9/25/2025.
• Purchased $1,001 - $15,000 in shares of Rollins NYSE: ROL on 9/25/2025.
• Purchased $1,001 - $15,000 in shares of SAP NYSE: SAP on 9/25/2025.
• Purchased $1,001 - $15,000 in shares of MGP Ingredients NASDAQ: MGPI on 9/25/2025.

Ingredion Stock Down 0.8%

INGR stock opened at $119.22 on Friday. The business has a 50-day moving average of $124.02 and a 200-day moving average of $130.53. Ingredion Incorporated has a fifty-two week low of $118.56 and a fifty-two week high of $155.44. The company has a debt-to-equity ratio of 0.41, a current ratio of 2.78 and a quick ratio of 1.81. The stock has a market capitalization of $7.65 billion, a P/E ratio of 11.63, a P/E/G ratio of 0.98 and a beta of 0.74.

Ingredion (NYSE:INGR - Get Free Report) last issued its quarterly earnings results on Friday, August 1st. The company reported $2.87 EPS for the quarter, beating the consensus estimate of $2.78 by $0.09. Ingredion had a return on equity of 19.04% and a net margin of 9.24%.The firm had revenue of $1.83 billion during the quarter, compared to analysts' expectations of $1.89 billion. During the same period in the prior year, the firm posted $2.87 earnings per share. The business's quarterly revenue was down 2.4% compared to the same quarter last year. Ingredion has set its FY 2025 guidance at 11.100-11.600 EPS. On average, sell-side analysts anticipate that Ingredion Incorporated will post 11.14 earnings per share for the current fiscal year.

Ingredion Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, October 21st. Stockholders of record on Wednesday, October 1st were given a dividend of $0.82 per share. This is an increase from Ingredion's previous quarterly dividend of $0.80. This represents a $3.28 annualized dividend and a dividend yield of 2.8%. The ex-dividend date of this dividend was Wednesday, October 1st. Ingredion's payout ratio is currently 32.00%.

Insiders Place Their Bets

In other Ingredion news, CEO James P. Zallie sold 36,287 shares of the firm's stock in a transaction on Tuesday, August 12th. The stock was sold at an average price of $126.52, for a total value of $4,591,031.24. Following the sale, the chief executive officer owned 50,129 shares of the company's stock, valued at approximately $6,342,321.08. This trade represents a 41.99% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, SVP Larry Fernandes sold 850 shares of the firm's stock in a transaction on Monday, August 4th. The shares were sold at an average price of $128.39, for a total value of $109,131.50. Following the completion of the sale, the senior vice president directly owned 31,171 shares in the company, valued at approximately $4,002,044.69. This represents a 2.65% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 37,137 shares of company stock worth $4,700,163. Company insiders own 2.30% of the company's stock.

Institutional Investors Weigh In On Ingredion

A number of large investors have recently added to or reduced their stakes in the stock. Migdal Insurance & Financial Holdings Ltd. grew its position in Ingredion by 40.2% during the first quarter. Migdal Insurance & Financial Holdings Ltd. now owns 279 shares of the company's stock worth $38,000 after buying an additional 80 shares in the last quarter. Retirement Guys Formula LLC boosted its holdings in shares of Ingredion by 5.7% in the 1st quarter. Retirement Guys Formula LLC now owns 1,566 shares of the company's stock valued at $212,000 after purchasing an additional 84 shares in the last quarter. Vista Investment Management boosted its holdings in shares of Ingredion by 0.8% in the 2nd quarter. Vista Investment Management now owns 10,789 shares of the company's stock valued at $1,463,000 after purchasing an additional 89 shares in the last quarter. Wealthspire Advisors LLC boosted its holdings in shares of Ingredion by 5.8% in the 1st quarter. Wealthspire Advisors LLC now owns 1,685 shares of the company's stock valued at $228,000 after purchasing an additional 92 shares in the last quarter. Finally, Teza Capital Management LLC boosted its holdings in shares of Ingredion by 4.2% in the 2nd quarter. Teza Capital Management LLC now owns 2,275 shares of the company's stock valued at $309,000 after purchasing an additional 92 shares in the last quarter. Institutional investors and hedge funds own 85.27% of the company's stock.

Analyst Ratings Changes

INGR has been the topic of several research analyst reports. Oppenheimer set a $136.00 price objective on Ingredion in a research note on Wednesday. Weiss Ratings reiterated a "buy (b)" rating on shares of Ingredion in a research note on Wednesday, October 8th. Wall Street Zen upgraded Ingredion from a "hold" rating to a "buy" rating in a research note on Sunday, October 19th. Finally, UBS Group lowered their target price on Ingredion from $144.00 to $130.00 and set a "neutral" rating on the stock in a research note on Monday, October 6th. Three investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $143.40.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan's 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027. McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan's 9th Congressional District. She declared candidacy for the 2026 election. Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor's degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

About Ingredion

Ingredion Incorporated, together with its subsidiaries, manufactures and sells sweeteners, starches, nutrition ingredients, and biomaterial solutions derived from wet milling and processing corn, and other starch-based materials to a range of industries in North America, South America, the Asia Pacific, Europe, the Middle East, and Africa.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.